Loading organizations...
§ Private Profile · São Paulo, Sao Paulo, Brazil
Home-based healthcare services provider offering lab tests, vaccines, and hospital services for patients in Brazil, using proprietary technology.
ISA Saúde, a São Paulo, Brazil-based home healthcare provider, offers a range of services including lab tests, vaccines, infusions, and palliative care through a network of autonomous health professionals. The company operates in over 60 cities across 7 states, managing 1,500 daily attendings with a network of 4,000 professionals. ISA Saúde secured R$160 million in Series B funding in 2023, led by IFC, with participation from IDB Lab, Dalus Capital, and Endeavor Catalyst. It expanded its offerings and reach through the acquisition of Saúde C, integrating its services and adding Alberto Ciccone as commercial head. Utilizing an asset-light model, ISA Saúde processes samples in its own São Paulo lab or partner facilities, aiming for up to 50% lower costs than traditional providers. The organization was founded in 2017 by brothers Fernando Pares and David Pares.
ISA Saúde has raised $41.7M across 2 funding rounds.
ISA Saúde has raised $41.7M in total across 2 funding rounds.
ISA Saúde has raised $41.7M in total across 2 funding rounds.
ISA Saúde's investors include Dalus Capital, Endeavor Catalyst, Canary, Endeavor Scale-Up, FIR Capital, Kortex Ventures, MatterScale, Vox Capital.
ISA Saúde has raised $41.7M across 2 funding rounds. Most recently, it raised $30.0M Series B in December 2025.
| Date | Round | Lead Investors | Other Investors | Status |
|---|---|---|---|---|
| Dec 18, 2025 | $30M Series B | — | Dalus Capital, Endeavor Catalyst | Announced |
| Aug 10, 2022 | $11.7M Series A | — | Canary Ventures, Endeavor Scale UP, FIR Capital, Kortex Ventures, MatterScale, VOX Capital | Announced |